Expertise in
6
conditions

Christophe Bergeron

Lyon, FR 
Expertise in
6
conditions
Lyon, FR 

Overview

Christophe Bergeron practices practicing medicine in Lyon, France.

Mr. Bergeron is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Wilms Tumor, Rhabdomyosarcoma, Mesenchymoma, Nephrectomy, and Orchiectomy.

He is actively involved in clinical research, co-authoring 89 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Lyon, France
Other Locations
Paris, France
Cergy, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Enrollment Status: Completed
Publish Date: December 01, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Enrollment Status: Completed
Publish Date: November 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
International Randomized Phase II Trial of the Combination of Vincristine and Irinotecan With or Without Temozolomide (VI or VIT) in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma
International Randomized Phase II Trial of the Combination of Vincristine and Irinotecan With or Without Temozolomide (VI or VIT) in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma
Enrollment Status: Completed
Publish Date: September 18, 2019
Intervention Type: Drug
Study Phase: Phase 2
Immunomonitoring of Children With Neuroblastoma for the Development of Antitumor Immunotherapy Strategies
Immunomonitoring of Children With Neuroblastoma for the Development of Antitumor Immunotherapy Strategies
Enrollment Status: Unknown
Publish Date: August 23, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

89 Total Publications

Erratum: Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study.
Erratum: Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 06, 2025

Frequently Asked Questions about Christophe Bergeron

Is Christophe Bergeron a top-rated expert for Wilms Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Christophe Bergeron is classified as an Distinguished expert for Wilms Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christophe Bergeron participate in research or clinical trials?

Yes. Christophe Bergeron has published 89 articles and abstracts on conditions like Wilms Tumor. You can view a list of Christophe Bergeron's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bergeron's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile